Abstract
INTRODUCTION
Bone defects caused tumors sometimes may not heal with bone tissue. In such cases, bone defects may need to be filled with bone graft materials to facilitate or start healing. The purpose of our study is to compare results of glass graft(GG) (GlassBone NORAKER) and tricalcium phosphate (TCP) grafts that we use in benign bone cysts clinically and radiologically.
METHODS
41 patients with benign bone tumors (mostly simple bone cysts (SBC) and aneurysmal bone cysts (ABC) ) had been treated between either glass graft or tricalcium phosphate graft between 2013-2015. Patients were divided into two groups as those treated with GG and TCP grafts. Graft consolidation evaluated radiologically with x-rays monthly.
RESULTS
There were 20 men and 21 women (51.2%) with a mean age of 22.0 years (range 14-32 years). In patients using GG, compared to patients using TCP, radiological consolidation was observed faster between 14.-16. months (p = 0.0001).
DISCUSSION AND CONCLUSION
We conclude that in the treatment of benign bone tumors glassbone can be used as an alternative to tricalcium phosphate grafts. We also noticed that patients treated with glassbone showed a faster rate of fusion radiologically.
Keywords: bioactive glass, tricalcium phosphate, bone tumor
